BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.17.5.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Asia/Manila
BEGIN:STANDARD
TZOFFSETFROM:+0800
TZOFFSETTO:+0800
TZNAME:PST
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Africa/Johannesburg
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0200
TZNAME:SAST
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Australia/Melbourne
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20230401T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20230930T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20240406T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20241005T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20240310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20241103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Rome
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20230312T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20231105T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20240310T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20241103T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20250309T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20251102T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/La_Paz
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0400
TZNAME:-04
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240723T081500
DTEND;TZID=America/New_York:20240723T121500
DTSTAMP:20240926T165526Z
CREATED:20240722T154732Z
LAST-MODIFIED:20240926T165526Z
UID:61362-1721722500-1721736900@globalbiodefense.com
SUMMARY:Heritable Genetic Modification in Food Animals
DESCRIPTION:An ad hoc committee appointed by the National Academies to explore heritable genetic modifications of food animals will meet from 23-24 July 2024 to discuss Oversight and Food Safety Concerns Posed by Heritable Genetic Modification in Food Animals. \nThis committee will address methods for heritable genetic modifications and identify risks and health hazards to humans\, animals\, and the environment. Furthermore\, this study will identify challenges associated with long term effects of heritable genetic modifications and identification of study design challenges when researching heritable genetic modifications in food animals. Agenda topics include: \n\nRecent regulatory activities regarding HGM animals\nAllergenic potential of HGM animal food products\nScientific and legal aspects of proposed changes to Guidance for Industry\nMOU with FDA for coordinating oversight of HGM animals\nRisk assessment and demonstration of safety of foods from HGM animals\n\nThe public part of the workshop will take place from 8:15 AM- 12:15 PM Eastern. Register to participate via webcast here. Source: National Academies of Sciences
URL:https://globalbiodefense.com/event/heritable-genetic-modification-in-food-animals/
LOCATION:Keck Center\, 500 5th Street Northwest\, Washington\, DC\, 20001\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240813
DTEND;VALUE=DATE:20240815
DTSTAMP:20240926T165526Z
CREATED:20240722T152250Z
LAST-MODIFIED:20240926T165526Z
UID:61355-1723507200-1723679999@globalbiodefense.com
SUMMARY:Assessing and Navigating Biosecurity Concerns and Benefits of Artificial Intelligence Use in the Life Sciences
DESCRIPTION:A National Academies committee will host a public information gathering session August 13-14\, 2024 featuring panels discussing the benefits and biosecurity concerns of AI-enabled biological design tools and biological data. \nThis is the first in-person meeting of the consensus study\, Assessing and Navigating Biosecurity Concerns and Benefits of Artificial Intelligence Use in the Life Sciences. The open session of this information gathering meeting will include initial briefings containing information relevant to study issues. The committee will also meet in closed session for project planning and review of topics and speakers for remaining meetings. \nThis event is available to attend either in-person or online from 8:00 AM – 5:00 PM ET. This meeting will include initial briefings containing information relevant to study issues. Please register today to receive updates as they become available.
URL:https://globalbiodefense.com/event/assessing-and-navigating-biosecurity-concerns-and-benefits-of-artificial-intelligence-use-in-the-life-sciences/
LOCATION:Keck Center\, 500 5th Street Northwest\, Washington\, DC\, 20001\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240826T143000
DTEND;TZID=America/New_York:20240826T160000
DTSTAMP:20240815T204408Z
CREATED:20240815T204408Z
LAST-MODIFIED:20240815T204408Z
UID:61760-1724682600-1724688000@globalbiodefense.com
SUMMARY:New Approaches to Vaccine Communications
DESCRIPTION:New Approaches to Vaccine Communications will be held on online on Monday\, August 26. \nEach fall and winter season\, public health professionals help their communities make informed decisions about vaccines through compelling and timely messages. This webinar will introduce newly tested messages to encourage routine and recommended vaccinations for children and adults. Attendees will access new messaging approaches that can inspire openness and curiosity about vaccines. \nTopics will include: \n\nMessages that build trust in vaccines among vaccine-hesitant people.\nUpdated 2024 guidance for annual vaccines\, including the flu and COVID-19.\nTools and tips for building trust with communities through innovative and accessible vaccine content.\n\nPlease visit the Public Health Communications Collaborative for more information or register here.
URL:https://globalbiodefense.com/event/new-approaches-to-vaccine-communications/
LOCATION:https://us06web.zoom.us/webinar/register/1417230409975/WN_yC4o5JcAS8yCUTEXIXiUbg?_hsmi=320066972#/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240905
DTEND;VALUE=DATE:20240907
DTSTAMP:20240505T185234Z
CREATED:20240505T185144Z
LAST-MODIFIED:20240505T185234Z
UID:61176-1725494400-1725667199@globalbiodefense.com
SUMMARY:APBA Annual Biorisk Conference 2024
DESCRIPTION:The 17th A-PBA Annual Biorisk Conference in conjunction with the BRAP 7th Annual Convention and 4th International Forum will be held 5-6 September in Quezon City\, the Philippines. Pre-conference events will be held 3-4 September. \nAbstracts are currently being accepted until 30 May for poster entries. Themes include: \n\nLaboratory biosafety and biosecurity\nBest practices in biorisk management\nInfection control\, patient safety and related fields\nOne Health and antimicrobial resistance\nEmerging biotechnology\nPublic health\nDual use research of concern\n\nPlease visit the BRAP website for more information.
URL:https://globalbiodefense.com/event/apba-annual-biorisk-conference-2024/
LOCATION:Crowne Plaza Manila Galleria\, Ortigas Ave\, Corner Asian Development Bank Ave\, Quezon City\, 1100\, Philippines
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240920
DTEND;VALUE=DATE:20240924
DTSTAMP:20240209T035906Z
CREATED:20240209T035906Z
LAST-MODIFIED:20240209T035906Z
UID:59960-1726790400-1727135999@globalbiodefense.com
SUMMARY:8th World One Health Congress
DESCRIPTION:The Global One Health Community is organizing the 8th World One Health Congress in Cape Town\n20 September – 23 September 2024. \nThe Congress will bring together One Health stakeholders\, from science researchers\, policymakers\, representatives of international institutions\, civil society to the private sector from around the world to address one health science\, antimicrobial agents and resistance\, and science policy interface. \nPlease visit the 8th World One Health Congress website for more information on abstract submission and registration.
URL:https://globalbiodefense.com/event/8th-world-one-health-congress/
LOCATION:Cape Town International Convention Centre\, 1 Lower Long Street\, Cape Town\, 8001\, South Africa
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240923
DTEND;VALUE=DATE:20240925
DTSTAMP:20240623T192520Z
CREATED:20240111T185900Z
LAST-MODIFIED:20240623T192520Z
UID:59604-1727049600-1727222399@globalbiodefense.com
SUMMARY:Clinton Global Initiative 2024 Meeting
DESCRIPTION:The Clinton Global Initiative 2024 Meeting will convene on 23-24 September 2024 in New York\, NY. \n\n\n\nThe CGI 2024 Meeting\, timed to be alongside the U.N. General Assembly\, will bring together business\, government\, and civil society leaders to build upon over 4\,000 Commitments to Action since CGI was first founded – driving progress on climate resilience\, inclusive economic growth and recovery\, health equity\, humanitarian response\, equality for women and girls\, and other issues. \n\n\n\nHighlights from the CGI 2023 Meeting program include: \n\n\n\n\nPresident Clinton opening CGI 2023 with a special conversation with His Holiness Pope Francis via remote link\, on what it takes to keep going on the most pressing global challenges of our time like climate change\, the refugee crisis\, the welfare of children\, and the mission and projects of the Bambino Gesù Children’s Hospital. Watch the full conversation between President Clinton and His Holiness Pope Francis here.\n\n\n\nSecretary Clinton and Treasury Secretary Janet Yellen discussing the care economy\, the economic response to the COVID-19 pandemic\, U.S. foreign policy\, and more in a fireside chat. Watch the full conversation between Secretary Clinton and Secretary Yellen here.\n\n\n\nDr. Chelsea Clinton and partners announcing the CGI Women and Girls pillar\, a core focus area for CGI aimed specifically and ambitiously at achieving full equality and equity for women and girls once and for all. Read more on the launch of the CGI Women and Girls pillar.\n\n\n\nThe launch of the CGI Ukraine Action Network with 19 CGI commitment-makers\, in a session featuring Olena Zelenska\, First Lady of Ukraine\, the recipient of the 2023 Clinton Global Citizen Award. Read more on the launch of the Ukraine Action Network.\n\n\n\n\nAbout the Clinton Global Initiative \n\n\n\nFounded by President Bill Clinton in 2005\, the Clinton Global Initiative is a community of doers representing a broad cross section of society and dedicated to the idea that we can accomplish more together than we can apart.  Through CGI’s unique model\, more than 10\,000 organizations have launched more than 4\,000 Commitments to Action — new\, specific\, and measurable projects and programs – that are making a difference in the lives of more than 500 million people in 180 countries. \n\n\n\nFor information about CGI 2024 and highlights from the CGI 2023 Meeting please visit clintonglobal.org/2024. Further details on the meeting\, including the theme\, programming\, and featured attendees\, will be announced in the coming months.
URL:https://globalbiodefense.com/event/clinton-global-initiative-2024-meeting/
LOCATION:New York City\, New York\, NY\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240923
DTEND;VALUE=DATE:20240928
DTSTAMP:20240528T152329Z
CREATED:20240528T152329Z
LAST-MODIFIED:20240528T152329Z
UID:61286-1727049600-1727481599@globalbiodefense.com
SUMMARY:Virtual AMR Codeathon
DESCRIPTION:The National Center for Biotechnology Information (NCBI) is joining forces with the National Institute of Allergy and Infectious Diseases (NIAID) to co-host a virtual codeathon\, Resistance is Futile: A codeathon to combat antimicrobial resistance\, which will take place September 23-27\, 2024. \nThis event is an opportunity to explore the National Database of Antibiotic Resistant Organisms (NDARO) and related AMR data with NCBI Pathogen Detection tools\, such as the Isolates\, MicroBIGG-E\, and Antibiotic Susceptibility Test (AST) Browsers to identify additional data that may be useful for your project.  \nDuring the week-long codeathon\, you will collaborate with your team to accomplish the following objectives:  \n\nIdentify loss-of-function genetic variations that contribute to AMR.\nFind and classify mobile genetic elements that contribute to AMR in draft genomes. Note: This work could integrate sequence data with epidemiological\, transmission\, and antibiotic sensitivity testing data to identify patterns and directions of co-migrating of AMR genes or plasmids.\nElucidate AMR biomarkers for historically hard-to-predict bacterial species (e.g.\, Acinetobacter\, Pseudomonas).\n\nLearn more at the NCBI’s Virtual AMR Codeathon website. Applications are due by 28 July.
URL:https://globalbiodefense.com/event/virtual-amr-codeathon/
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240924T080000
DTEND;TZID=America/New_York:20240924T094500
DTSTAMP:20240810T141355Z
CREATED:20240810T141253Z
LAST-MODIFIED:20240810T141355Z
UID:61420-1727164800-1727171100@globalbiodefense.com
SUMMARY:Pandemics\, Climate\, Conflict: Preventing Future Shocks
DESCRIPTION:Pandemics\, Climate\, Conflict: Preventing Future Shocks is a hybrid UN General Assembly week side event hosted by the Pandemic Action Network (PAN)\, the Independent Panel for Pandemic Preparedness and Response\, and Resilience Action Network Africa (RANA). \nHow can this year’s UN Summit of the Future (Sept. 22-23) serve as a springboard for action in the year ahead? \nThis event will include former Heads of State and government\, senior policymakers\, and non-governmental leaders sharing their perspectives on the current political state of play\, opportunities\, and actions necessary to ensure we are prepared to respond to\, and prevent\, future global shocks. \nRSVP here.
URL:https://globalbiodefense.com/event/pandemics-climate-conflict-preventing-future-shocks/
LOCATION:United Nations Headquarters\, 405 E 45th St\, New York\, NY\, 10017\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240927T120000
DTEND;TZID=America/New_York:20240927T130000
DTSTAMP:20240927T002512Z
CREATED:20240927T002133Z
LAST-MODIFIED:20240927T002512Z
UID:61857-1727438400-1727442000@globalbiodefense.com
SUMMARY:Assessing and Navigating Biosecurity Concerns and Benefits of Artificial Intelligence Use in the Life Sciences
DESCRIPTION:This is the 2nd information gathering meeting of the consensus study\, Assessing and Navigating Biosecurity Concerns and Benefits of Artificial Intelligence Use in the Life Sciences. The open session of this information gathering meeting will include briefings containing information relevant to study issues followed by a discussion with the committee. \nThe convergence of artificial intelligence (AI) and life sciences is an emerging area of research and development with promising benefits and applications but may also have security implications. This committee will consider the ways in which AI-enabled biological design tools and biological data sets for training AI can increase and mitigate biosecurity risks\, specifically on concerns of transmissible biological threats that could pose significant epidemic and pandemic-scale consequences. \nThe agenda includes a panel on high-performance computing in life sciences and biological data resources and infrastructure. \nThis meeting will be held over zoom. A recording of the open meeting will be available after it has ended.
URL:https://globalbiodefense.com/event/assessing-and-navigating-biosecurity-concerns-and-benefits-of-artificial-intelligence-use-in-the-life-sciences-3/
LOCATION:Keck Center\, 500 5th Street Northwest\, Washington\, DC\, 20001\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241001T090000
DTEND;TZID=America/New_York:20241001T120000
DTSTAMP:20240927T002512Z
CREATED:20240927T001306Z
LAST-MODIFIED:20240927T002512Z
UID:61856-1727773200-1727784000@globalbiodefense.com
SUMMARY:Assessing and Navigating Biosecurity Concerns and Benefits of Artificial Intelligence Use in the Life Sciences
DESCRIPTION:This is the third in-person meeting of the consensus study\, Assessing and Navigating Biosecurity Concerns and Benefits of Artificial Intelligence Use in the Life Sciences. \nThe open session of this information gathering meeting will include briefings containing information relevant to study issues. The committee will also meet in closed sessions to discuss the report. \nThe convergence of artificial intelligence (AI) and life sciences is an emerging area of research and development with promising benefits and applications but may also have security implications. This committee will consider the ways in which AI-enabled biological design tools and biological data sets for training AI can increase and mitigate biosecurity risks\, specifically on concerns of transmissible biological threats that could pose significant epidemic and pandemic-scale consequences. \nHighlighted agenda topics include: \n\nUnderstanding Pathogenesis of Transmissible Biological Agents and Impact of AI\nOpportunities to Use AI in Medical Countermeasures Development\nHigh Performance Computing in the Life Sciences\n\nThis meeting will be held over zoom. A recording of the open meeting will be available after it has ended.
URL:https://globalbiodefense.com/event/assessing-and-navigating-biosecurity-concerns-and-benefits-of-artificial-intelligence-use-in-the-life-sciences-2/
LOCATION:Keck Center\, 500 5th Street Northwest\, Washington\, DC\, 20001\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241001T120000
DTEND;TZID=America/New_York:20241001T130000
DTSTAMP:20240927T000657Z
CREATED:20240927T000529Z
LAST-MODIFIED:20240927T000657Z
UID:61855-1727784000-1727787600@globalbiodefense.com
SUMMARY:Accelerating Drug Discovery with Machine Learning
DESCRIPTION:Advances in machine learning and its impacts on daily life have captured the imagination of headlines. However\, significant challenges abound in accelerating drug discovery with machine learning\, a field with many unknown unknowns. \nAs part of Advancing Drug Discovery: A Webinar Series of the National Academies of Sciences\, Engineering and Medicine\, a session on Accelerating Drug Discovery with Machine Learning will be held on Tuesday\, October 1st. \nPlease visit the National Academies’ website for more information.
URL:https://globalbiodefense.com/event/accelerating-drug-discovery-with-machine-learning/
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241007
DTEND;VALUE=DATE:20241010
DTSTAMP:20240927T041344Z
CREATED:20240927T041238Z
LAST-MODIFIED:20240927T041344Z
UID:61865-1728259200-1728518399@globalbiodefense.com
SUMMARY:40th NRL Workshop on Infectious Disease Testing
DESCRIPTION:Australia’s 40th NRL Workshop on Infectious Disease Testing will be held 7-9 October in Melbourne \nExplore a comprehensive lineup of expert speakers and insightful sessions\, covering the latest advancements infectious diseases. \nHighlighted agenda topics include: \n\nEvaluation of the Roche Cobas HIV-1/HIV-2 Qualitative assay for the diagnosis of HIV-1\nThe Role of Diagnostics to Support Reaching the Unreached\nRapid POC self-tests for diagnosis of acute syphilis\nQuality control in diagnostic kits: Enhancing wellbeing through effective panel prep for HCV and HBV\nCapacity building for the diagnosis of Japanese encephalitis virus in Australia\nReview of syphilis serology tests and testing strategies\nThe complexities of diagnosing congenital syphilis infections\nRapid syndromic testing in the ED\nPreparing for the next pandemic\nNew tools in the evolving battle against respiratory pathogens\nOptimizing HRP conjugated antigens for SARS-CoV-2 total antibody detection applications in serological surveys\n\nPlease visit the NRL Workshop on Infectious Disease Testing website for more information. \n  \n\nABOUT NRL \nAustralia’s National (Serology) Reference Laboratory (NRL) was first established as part of the Australian Government’s HIV and AIDS strategy in 1985 and later that year was designated as a World Health Organisation (WHO) Collaborating Centre for Diagnostics and Laboratory Support for HIV and AIDS and Other Blood-borne Infections. \nOver time\, NRL has emerged as a global leader in the science of quality for infectious disease testing and we believe that good science makes all the difference because the outcome of testing has such a significant impact on individuals and the community. \n 
URL:https://globalbiodefense.com/event/40th-nrl-workshop-on-infectious-disease-testing/
LOCATION:Park Hyatt Melbourne\, 1 Parliament Square\, Melbourne\, VIC\, 3002\, Australia
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20241009T090000
DTEND;TZID=America/Los_Angeles:20241009T163000
DTSTAMP:20240926T171511Z
CREATED:20240926T165550Z
LAST-MODIFIED:20240926T171511Z
UID:61838-1728464400-1728491400@globalbiodefense.com
SUMMARY:The Changing DEI Legislation and Policy Landscape and Its Impact on Health and Public Health’s Workforce
DESCRIPTION:The National Academies Roundtable on the Promotion of Health Equity will host a public hybrid workshop on October 9\, 2024 in Washington\, DC to explore the impact of DEI legislation and policies on achieving a diverse health care and public health workforce. \nFollowing the June 2023 Supreme Court ruling against affirmative action in colleges and universities\, many states introduced legislation in higher education to disband DEI efforts. As of August 2024\, 86 bills in 28 states have introduced DEI legislation for colleges and universities to disband diversity offices or staff\, ban mandatory diversity training\, prohibit institutions to use diversity statements in hiring and promotion\, or bar colleges for considering race\, sex\, ethnicity\, or national origin in admissions or employment. \nSpeakers will explore recent changes in state legislature and policies affecting the health care and public health workforce; examine the impact of these policy changes on medical and public health training\, curriculum\, and health research; discuss student recruitment and faculty recruitment and retention for educating and training the health and public health’s workforce; and investigate potential solutions for mitigating adverse impacts of policy changes. \nTo register\, please visit the National Academies’ Exploring the Changing Diversity\, Equity\, and Inclusion Legislation and Policy Landscape and Its Impact on Health and Public Health’s Workforce\, Education\, Training\, and Research: A Workshop page.
URL:https://globalbiodefense.com/event/the-changing-dei-legislation-and-policy-landscape-and-its-impact-on-health-and-public-healths-workforce/
LOCATION:Keck Center\, 500 5th Street Northwest\, Washington\, DC\, 20001\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241011T110000
DTEND;TZID=America/New_York:20241011T130000
DTSTAMP:20240926T205017Z
CREATED:20240926T204624Z
LAST-MODIFIED:20240926T205017Z
UID:61846-1728644400-1728651600@globalbiodefense.com
SUMMARY:Review of CDC COVID-19 Vaccine Safety Research and Communications Meeting 3
DESCRIPTION:The Committee to Review the CDC’s COVID-19 Vaccine Safety Research and Communications will host a two-hour public comment session on 11 October 2024. \nPre-registered attendees will have the opportunity to provide virtual public comments and suggestions on how to improve CDC’s vaccine safety research\, and how to make vaccine safety and risk information better and easier to understand. \nComments and suggestions can pertain to vaccines used in emergencies\, like COVID-19\, and vaccines used in non-emergency situations (MMR\, polio\, etc.). \nLearn more at the National Academies’ Review of CDC COVID-19 Vaccine Safety Research and Communications Meeting 3 (part 1). \n\nBackground \nAn ad hoc committee of the National Academies of Sciences\, Engineering\, and Medicine will evaluate the Centers for Disease Control and Prevention (CDC) Immunization Safety Office (ISO) systems\, methods\, and processes for monitoring COVID-19 vaccine safety during the U.S. COVID-19 vaccination program and provide recommendations for sustaining\, maintaining\, and strengthening CDC ISO current monitoring systems moving forward. \nSpecifically\, the committee will assess the statistical and epidemiological methods and processes employed to detect and evaluate potential safety problems with the U.S. COVID-19 vaccines; catalog the findings from safety monitoring including pertinent positive and negative findings; and evaluate CDC external communications about its safety monitoring systems\, the findings of COVID-19 vaccine safety monitoring\, and vaccination and clinical guidance recommendations to healthcare professionals\, public health officials\, and the public. \nSource: National Academies \n 
URL:https://globalbiodefense.com/event/review-of-cdc-covid-19-vaccine-safety-research-and-communications-meeting-3/
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241017T190000
DTEND;TZID=America/New_York:20241017T190000
DTSTAMP:20241014T181339Z
CREATED:20241014T181306Z
LAST-MODIFIED:20241014T181339Z
UID:61930-1729191600-1729191600@globalbiodefense.com
SUMMARY:Biodefense MS Information Session
DESCRIPTION:Master of Biodefense Information Session: Prospective students are invited to attend an information session on 17 October 2024 to hear more about the Master of Biodefense program offered at the Schar School of Policy and Government at George Mason University. \nLearn more about the program\, application process\, student experience\, and graduate outcomes. The program is offered in part-time\, full-time\, online\, in-person\, and hybrid formats \nThis session admissions will be led by the Graduate Admissions team. \nAfter registering\, you will receive an email with a zoom link the morning of the session. \nVisit the list of ongoing events at the Schar School here.
URL:https://globalbiodefense.com/event/biodefense-ms-information-session/
LOCATION:
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2024/02/gmu-schar-school-ms-biodefense-1200.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241022
DTEND;VALUE=DATE:20241024
DTSTAMP:20240926T172758Z
CREATED:20240926T172607Z
LAST-MODIFIED:20240926T172758Z
UID:61840-1729555200-1729727999@globalbiodefense.com
SUMMARY:Potential Research Priorities to Inform Readiness and Response to Highly Pathogenic Avian Influenza A (H5N1)
DESCRIPTION:The National Academies of Sciences\, Engineering\, and Medicine will organize a public workshop  on the Potential Research Priorities to Inform Readiness and Response to Highly Pathogenic Avian Influenza A (H5N1) from 22-23 October 2024 via webcast. \nThe workshop discussions may help inform future research that could provide local\, national\, and global communities with information about virus transmission\, mitigation of risks\, and appropriate measures to prevent the spread of disease. \nKey concepts discussed include: \n\nWhat is the relevant scientific evidence and state of current scientific knowledge?\nWhat research is ongoing and what new results can be anticipated?\nWhat gaps remain and what research should be initiated?\n\nPlease visit the National Academies’ Potential Research Priorities to Inform Readiness and Response to Highly Pathogenic Avian Influenza A (H5N1) workshop website for more information. \n\nCall for Public Comment: \nThis Online Public Comment Portal is available for public comments and resource submissions to the workshop planning committee. Information that is submitted will remain confidential and be accessible only to project staff and the planning committee. \nComments may be submitted until October 23\, 2025\, at 11:59 PM ET.
URL:https://globalbiodefense.com/event/potential-research-priorities-to-inform-readiness-and-response-to-highly-pathogenic-avian-influenza-a-h5n1/
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241024T130000
DTEND;TZID=America/New_York:20241024T143000
DTSTAMP:20240926T205001Z
CREATED:20240926T204928Z
LAST-MODIFIED:20240926T205001Z
UID:61848-1729774800-1729780200@globalbiodefense.com
SUMMARY:A Long COVID Diagnosis: Implications for Social\, Behavioral\, and Economic Sciences
DESCRIPTION:A Long COVID diagnosis has far-reaching impacts on individuals and communities. While most people recover fully from COVID-19\, tens of millions continue to experience debilitating symptoms that affect their daily lives\, including persistent fatigue\, cognitive challenges\, and social isolation. As these challenges persist\, it is crucial to understand and address the social and behavioral dimensions of Long COVID to improve the well-being and quality of life of those affected \nThis webinar\, hosted by the Societal Experts Action Network in partnership with the National Academies’ Health and Medicine Division\, will bring together leading experts\, patient advocates\, and policymakers to discuss the implications of the newly defined Long COVID condition. This event will focus on the psychosocial aspects of the condition\, examining how it affects identity\, social support\, and community engagement. \nPlease visit the National Academies’ A Long COVID diagnosis: Implications for social\, behavioral\, and economic sciences event page for more information.
URL:https://globalbiodefense.com/event/a-long-covid-diagnosis-implications-for-social-behavioral-and-economic-sciences-2/
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241111
DTEND;VALUE=DATE:20241114
DTSTAMP:20240505T173640Z
CREATED:20240505T173640Z
LAST-MODIFIED:20240505T173640Z
UID:61165-1731283200-1731542399@globalbiodefense.com
SUMMARY:Pandemic Preparedness: Achievements\, Current Challenges\, and New Frontiers
DESCRIPTION:The Pandemic Preparedness: Achievements\, Current Challenges\, and New Frontiers conference will be held 11-13 November 2024 in Trieste\, Italy. \nJoin world-renowned scientists discussing the known and emerging viruses representing a potential epidemic risk. \nThe event will focus on prevention\, surveillance\, detection\, drug discovery\, treatment\, and cooperation\, to tackle challenges and implementing response strategies related to the threat posed by potential pandemic outbreaks. \nHighlighted topics include: \n\nEmerging and re-emerging viruses with pandemic potential\nRisk of viral zoonoses and its mitigation\nDiagnostics\, surveillance and capacity building in resources limited settings\nImmunization and preventive approaches\nDrug discovery: stocking the shelves for the next pandemic\nBiosafety and Biosecurity when dealing with viral infections\nMultidisciplinary approaches\, infrastructure\, and cooperation\nFuture challenges in pandemic preparedness\n\nThe conference is organized by Area Science Park\, in conjunction with the International Centre for Genetic Engineering and Biotechnology – ICGEB\, in the framework of PRP@CERIC project. \nPlease visit the Pandemic Preparedness: Achievements\, Current Challenges\, and New Frontiers website for more information.
URL:https://globalbiodefense.com/event/pandemic-preparedness-achievements-current-challenges-and-new-frontiers/
LOCATION:Savoia Excelsior Palace\, Riva del Mandracchio\, Trieste\, 34124\, Italy
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241113
DTEND;VALUE=DATE:20241118
DTSTAMP:20240218T222149Z
CREATED:20240218T221646Z
LAST-MODIFIED:20240218T222149Z
UID:60041-1731456000-1731887999@globalbiodefense.com
SUMMARY:ASTMH 2024 - American Society of Tropical Medicine & Hygiene
DESCRIPTION:The American Society of Tropical Medicine & Hygiene will host the ASTMH 2024 Annual Meeting from 13-17 November 2024 in New Orleans\, Louisiana. \nThe meeting is designed for researchers\, professors\, government and public health officials\, military personnel\, travel clinic physicians\, practicing physicians in tropical medicine\, students\, and all healthcare providers working in the fields of tropical medicine\, hygiene\, and global health. \nLast year’s ASTMH Annual Meeting included over 3\,000 total presentations\, with about half being microbe-focused\, 13% vector-focused\, 15% clinically-focused\, 13% globally-focused and 6% intervention-focused. \nLearn more and register for the ASTMH 2024 Annual Meeting.
URL:https://globalbiodefense.com/event/astmh-2024-american-society-of-tropical-medicine-hygiene/
LOCATION:Ernest N. Morial New Orleans Convention Center\, 900 Convention Center Blvd\, New Orleans\, LA\, 70130\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241114T093000
DTEND;TZID=America/New_York:20241114T170000
DTSTAMP:20241107T191142Z
CREATED:20241107T191142Z
LAST-MODIFIED:20241107T191142Z
UID:61954-1731576600-1731603600@globalbiodefense.com
SUMMARY:Integration Site Analysis During Long Term Follow-Up for Gene Therapies with Integrating Viral Vectors
DESCRIPTION:The FDA’s Center for Biologics Evaluation and Research (CBER) Office of Therapeutic Products (OTP) is hosting a virtual scientific public workshop on the clinical use of integration site analysis (ISA) during long term follow-up following administration of gene therapies with integrating viral vectors. \nIn this workshop\, FDA will convene a panel of external experts to discuss the risk of insertional mutagenesis and best practices for ISA method design\, data analysis\, and clinical interpretation. The workshop participants will include research scientists with experience in vector design and ISA\, as well as clinician-scientists with expertise in clinical interpretation of ISA data. \nFocus for this Workshop\nAs of 2024\, twelve approved and hundreds of investigational cell-based gene therapies use integrating viral vectors. While stable integration may have considerable therapeutic benefits\, integration into genomic DNA can alter host gene expression and may contribute to secondary malignancies via insertional mutagenesis. Additionally\, the choice of vector (e.g.\, lentivirus versus gammaretrovirus) and cell substrate (e.g.\, T cells versus CD34+ cells) may also contribute to this risk. \nISA is the established approach to identify vector insertion sites. However\, ISA method design and data interpretation are highly complex and product-specific. Moreover\, ISA methods may be costly and challenging to perform. There is a critical need to understand the best practices for product design and ISA method design\, execution\, and interpretation to facilitate efficient evaluation of complex gene therapy products and protect the public from potential serious adverse events. \nThis workshop will include discussions on the following topics: \n\nEffects of Cell Substrate and Vector Design on the Risk of Vector Insertion-Related Adverse Events\nISA Methodology\, Assay Design\, and Analytical Capabilities\nISA Analysis\, Quality Control\, and Data Reporting\nClinical Follow-Up for Integrating Viral Vectors\nUsing ISA to Inform Clinical Decisions\n\nFor current guidance on the role of ISA in clinical follow-up\, please refer to section V.F “Special Considerations Regarding Integrating Vectors” of the FDA Guidance for Industry “Long Term Follow-Up After Administration of Human Gene Therapy Products” dated January 2020 (https://www.fda.gov/media/113768/download). \n Registration is required.
URL:https://globalbiodefense.com/event/integration-site-analysis-during-long-term-follow-up-for-gene-therapies-with-integrating-viral-vectors/
LOCATION:
CATEGORIES:Conference,Government Hosted
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241118
DTEND;VALUE=DATE:20241120
DTSTAMP:20240623T192942Z
CREATED:20240125T194316Z
LAST-MODIFIED:20240623T192942Z
UID:59697-1731888000-1732060799@globalbiodefense.com
SUMMARY:G20 Summit Rio 2024
DESCRIPTION:The G20 Leaders’ Summit is scheduled for 18-19 November 2024\, in Rio de Janeiro\, with the presence of the leaders of the 19 member countries\, plus the African Union and the European Union. \nThe G20 brings together the countries with the largest economies in the world. The member states meet annually to discuss economic\, political and social initiatives. The group defines itself as the main forum for international economic cooperation. \nThe G20 countries account for half the world’s land mass\, two-thirds of the world’s total population\, and a staggering 85% or more of global GDP. These imply both a large magnitude of health burden on the one hand and a depth of experience and strong base of resources on the other. The G20 Health Working Group was established under the German Presidency in 2017 to develop a shared international agenda on issues such as strengthening health-care systems\, reducing malnutrition\, health-crisis management\, and scaling up the fight against pandemics; these are India’s domestic priorities too. \nIn addition to the summit\, more than 100 meetings of working groups and task forces will comprise the G20 event\, both face-to-face and virtual\, at technical and ministerial level\, in the host cities of Brasil’s five regions. The highlight will be the Summit in Rio de Janeiro. \nThe participating countries are Argentina\, Australia\, Brasil\, Canada\, China\, France\, Germany\, India\, Indonesia\, Italy\, Japan\, Mexico\, Republic of Korea\, Republic of South Africa\, Russia\, Saudi Arabia\, Turkey\, United Kingdom and the United States of America\, African Union and European Union. In addition\, invited guest countries and international organizations participate in the G20. Media reports indicate the Presidents of Russia\, China and Mexico will not be in attendance. State leaders from the other member states will likely attend. \nThe G20 troika system was officially adopted at the Cannes Summit (France) in 2011 as the framework for steering the G20 process. The “troika” consists of the current\, previous\, and next G20 presidencies and the three members cooperate with one another in preparing for the G20 Summit. During Brasil’s presidency\, we will work closely together with India (2023 presidency) and South Africa (2025 presidency). \nPlease visit the G20 Brasil 2024 website for more information on the full summit agenda.
URL:https://globalbiodefense.com/event/g20-summit-rio-2024/
LOCATION:Museu de Arte Moderna do Río de Janeiro\, Av. Infante Dom Henrique\, 85\, Rio de Janeiro\, Brazil
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241209
DTEND;VALUE=DATE:20241211
DTSTAMP:20240926T235823Z
CREATED:20240926T215537Z
LAST-MODIFIED:20240926T235823Z
UID:61854-1733702400-1733875199@globalbiodefense.com
SUMMARY:Enhancing the Resilience of Healthcare and Public Health Critical Infrastructure
DESCRIPTION:A planning committee of the National Academies’ Forum on Medical and Public Health Preparedness for Disasters and Emergencies will hold a workshop 9-10 December 2024 via webcast \nThe workshop will examine possible improvements to healthcare and public health infrastructure preparedness\, aiming to identify vulnerabilities to critical public health infrastructure and opportunities to reduce risks and improve physical and digital resilience. \nA workshop proceedings in brief will be published afterwards. \nThe workshop may include presentations and discussions that: \n\nIdentify common challenges\, key risks\, and vulnerabilities of HPH critical infrastructure\, including physical\, cyber\, supply chain\, and operational aspects\, through recent case studies and incidents.\nExamine the interdependencies of the HPH critical infrastructure sector and select other sectors (Energy\, Water and Wastewater Systems\, Transportation\, Emergency Services\, Food and Agriculture\, Information Technology\, and Communications Sectors) and the potential for cascading failures.\nHighlight opportunities to ensure continuity of operations through public-private partnerships\, collaboration\, and information sharing between HPH and interdependent critical infrastructure sectors.\nExplore strategies to reduce risks to critical infrastructure\, recover from impacts\, and improve the physical and digital resilience of HPH infrastructure (e.g.\, space\, staff\, stuff\, and systems) during steady state and in response\, particularly for infrastructure that supports populations who have been historically underserved\, marginalized\, and adversely affected (e.g.\, rural areas\, health care deserts\, etc.).\n\nPlease visit NASEM’s Enhancing the Resilience of Healthcare and Public Health Critical Infrastructure: A Workshop for more information.
URL:https://globalbiodefense.com/event/enhancing-the-resilience-of-healthcare-and-public-health-critical-infrastructure/
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241210
DTEND;VALUE=DATE:20241211
DTSTAMP:20240926T221353Z
CREATED:20240926T221353Z
LAST-MODIFIED:20240926T221353Z
UID:61852-1733788800-1733875199@globalbiodefense.com
SUMMARY:Frameworks Discussion for Assessing Dual-Use Potential in Bioeconomy Research
DESCRIPTION:This meeting is part of the Biological Threats in the Age of the Bioeconomy – A Workshop Series. \nExisting biosafety and biosecurity policies and frameworks\, which are focused on pathogens and toxins\, may not address concerns associated with advances in research and development of bioeconomy-relevant biotechnologies and biomanufacturing. This meeting will discuss existing frameworks and their relationship to the participating countries. \nThis activity is limited to participants with citizenship/nationality in the following countries:  Mexico\, Peru\, Argentina\, India\, and the United States. \nLearn more and register at the National Academies’ Adapting Frameworks for Assessing Dual-Use Potential in Bioeconomy Research Workshop #3 page.
URL:https://globalbiodefense.com/event/frameworks-discussion-for-assessing-dual-use-potential-in-bioeconomy-research/
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250121
DTEND;VALUE=DATE:20250124
DTSTAMP:20240926T221353Z
CREATED:20240926T221353Z
LAST-MODIFIED:20240926T221353Z
UID:61853-1737417600-1737676799@globalbiodefense.com
SUMMARY:Frameworks for Assessing Dual-Use Potential in Bioeconomy Research- Scenario Discussions
DESCRIPTION:This meeting is part of the Biological Threats in the Age of the Bioeconomy – A Workshop Series. \nExisting biosafety and biosecurity policies and frameworks\, which are focused on pathogens and toxins\, may not address concerns associated with advances in research and development of bioeconomy-relevant biotechnologies and biomanufacturing. This meeting will discuss existing frameworks and their relationship to the participating countries. \nThe meeting is limited to participants with citizenship/nationality in the following countries:  Mexico\, Peru\, Argentina\, India\, and the United States. \nLearn more and register at the National Academies’ Adapting Frameworks for Assessing Dual-Use Potential in Bioeconomy Research Workshop #4 page.
URL:https://globalbiodefense.com/event/frameworks-for-assessing-dual-use-potential-in-bioeconomy-research-scenario-discussions/
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250130T090000
DTEND;TZID=America/New_York:20250130T100000
DTSTAMP:20250124T205638Z
CREATED:20250124T205638Z
LAST-MODIFIED:20250124T205638Z
UID:62109-1738227600-1738231200@globalbiodefense.com
SUMMARY:Ask Us Anything: The State of Social Media for Public Health Communicators
DESCRIPTION:The Public Health Communications Collaborative will host a webinar entitled “Ask Us Anything: The State of Social Media for Public Health Communicators” on January 30\, 2025. \n“2025 kicked off with a public health crisis in Los Angeles\, the removal of fact-checking on Meta platforms\, and a new administration. Public health professionals and communicators across the country are feeling the impacts. At PHCC\, we believe public health communicators should not go it alone. Join your peers for a dynamic discussion on navigating social media now and learn practical ways to connect with your communities online. Share your questions and challenges with experts in communications and public health.” \nThe session covers the most pressing questions about social media and growing dis- and mis-information. You can share questions with your registration or ask them in real-time during the webinar. \n“More than ever\, public health communicators have complex jobs. Don’t do it alone. Instead\, ask us anything.” \nPlease visit the Public Health Communications Collaborative website for more information on resources and upcoming events.
URL:https://globalbiodefense.com/event/ask-us-anything-the-state-of-social-media-for-public-health-communicators/
LOCATION:https://us06web.zoom.us/webinar/register/6817376492099/WN_nqpyT9vXROW1DYgWbJ-vhA#/registration
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250206T060000
DTEND;TZID=America/New_York:20250206T070000
DTSTAMP:20250204T203645Z
CREATED:20250204T203645Z
LAST-MODIFIED:20250204T203645Z
UID:62181-1738821600-1738825200@globalbiodefense.com
SUMMARY:WHO EPI-WIN Webinar: Sudan Virus Disease Outbreak
DESCRIPTION:The World Health Organization (WHO) will give an overview of the current outbreak of Sudan Ebola virus disease on 6 February 2025. \nThe webcast event will happen at 12:00 Central European Time (6:00 am Eastern). \nSudan virus disease is a severe\, often fatal illness affecting humans and other primates that is due to Orthoebolavirus sudanense (Sudan virus)\, a viral species belonging to the same genus of the virus causing Ebola virus disease. \nThis webinar will provide an overview of the current outbreak of Sudan virus disease: what is known\, the current outbreak in Uganda\, and prevention and control measures. \nSpeakers \nDr Maria Van Kerkhove\, Director\, Epidemic and Pandemic Preparedness and Prevention (EPP)\, WHO \nDr Anais Legand\, Technical Officer\, Viral Harmorrhagic Fevers\, WHO \nPlease visit the WHO EPI-WIN Webinar: Sudan virus disease outbreak: what we know site for more information.
URL:https://globalbiodefense.com/event/who-epi-win-webinar-sudan-virus-disease-outbreak/
LOCATION:https://who.zoom.us/webinar/register/WN_pNMWtcgcQ46LQDYgxfdQsw#/registration
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250206T113000
DTEND;TZID=America/New_York:20250206T123000
DTSTAMP:20250204T050306Z
CREATED:20250204T043250Z
LAST-MODIFIED:20250204T050306Z
UID:62175-1738841400-1738845000@globalbiodefense.com
SUMMARY:State of Knowledge Regarding Transmission\, Spread and Management of Chronic Wasting Disease
DESCRIPTION:The NASEM Committee on the Review of Transmission and Geographic Spread of Chronic Wasting Disease in U.S. Cervid Populations will hold a public webinar on February 6\, 2025. \nThe discussion will center on release of a new report describing the state of knowledge regarding: \n\nHow CWD is transmitted among cervids\nThe current distribution of disease outbreaks\nThe effectiveness of current diagnostic\, prevention\, and control methods\n\nMembers of the committee will provide an overview of the report’s key messages and there will be an opportunity for audience Q&A. \nHighlighted committee members include: \n\nLonnie King\, Academy Professor and Dean Emeritus\, Ohio State University College of Veterinary Medicine\nMichael W. Miller\, Wildlife Veterinarian\nTiffany Marie Wolf\, Associate Professor\, College of Veterinary Medicine\, University of Minnesota\, Co-Director\, Minnesota Center for Prion Research and Outreach\nNicholas J. Haley\, Associate Professor\, Midwestern University College of Graduate Studies Department of Microbiology and Immunology\n\nPlease visit the National Academies’ State of Knowledge Regarding Transmission\, Spread and Management of Chronic Wasting Disease in U.S. Captive and Free-Ranging Cervid Populations: Report Release site for more information. \n 
URL:https://globalbiodefense.com/event/state-of-knowledge-regarding-transmission-spread-and-management-of-chronic-wasting-disease/
LOCATION:https://vimeo.com/event/4865105
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250211
DTEND;VALUE=DATE:20250213
DTSTAMP:20250204T045158Z
CREATED:20240926T221353Z
LAST-MODIFIED:20250204T045158Z
UID:61851-1739232000-1739404799@globalbiodefense.com
SUMMARY:Frameworks for Assessing Dual-Use Potential in Bioeconomy Research - Summary Discussion
DESCRIPTION:This meeting is part of the Biological Threats in the Age of the Bioeconomy – A Workshop Series and will conclude the select topic scenarios discussion from prior meetings\, and will also include a discussion of overall themes identified by the committee throughout the Workshop series. \nPlease visit the National Academies’ Adapting Frameworks for Assessing Dual-Use Potential in Bioeconomy Research Workshop site for more information. \nThis activity is limited to participants with citizenship/nationality in the following countries:  Mexico\, Peru\, Argentina\, India\, and the United States. \nSource: National Academies
URL:https://globalbiodefense.com/event/frameworks-for-assessing-dual-use-potential-in-bioeconomy-research-summary-discussion/
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20250319T130000
DTEND;TZID=Europe/Paris:20250319T193000
DTSTAMP:20250315T213817Z
CREATED:20250315T213817Z
LAST-MODIFIED:20250315T213817Z
UID:62221-1742389200-1742412600@globalbiodefense.com
SUMMARY:What Research is Important to Prepare for H5N1 Outbreaks?
DESCRIPTION:The World Health Organization will host a virtual meeting on 19 March to identify the knowledge gaps and priority research questions related to the development and evaluation of medical countermeasures to prepare for and respond to H5N1 outbreaks \nThe meeting will outline regulatory pathways for mRNA vaccines and other novel approaches and review other therapeutics\, including monoclonal antibodies and long-acting antivirals. \nH5N1 influenza virus infection can cause a range of diseases in humans\, from mild to severe and in some cases\, it can even be fatal. Symptoms reported have primarily been respiratory\, but conjunctivitis and other non-respiratory symptoms have also been reported. There have also been a few detections of A(H5N1) virus in persons who were exposed to infected animals or their environments but who did not show any symptoms. \nThe goose/Guangdong-lineage of H5N1 avian influenza viruses first emerged in 1996 and has been causing outbreaks in birds since then. Since 2020\, a variant of these viruses has led to an unprecedented number of deaths in wild birds and poultry in many countries. First affecting Africa\, Asia and Europe\, in 2021\, the virus spread to North America\, and in 2022\, to Central and South America. From 2021 to 2022\, Europe and North America observed their largest and most extended epidemic of avian influenza with unusual persistence of the virus in wild bird populations. \nSince 2022\, there have been increasing reports of deadly outbreaks among mammals also caused by influenza A(H5) – including influenza A(H5N1) – viruses. There are likely to be more outbreaks that have not been detected or reported. Both land and sea mammals have been affected\, including outbreaks in farmed fur animals\, seals\, sea lions\, and detections in other wild and domestic animals such as foxes\, bears\, otters\, raccoons\, cats\, dogs\, cows\, goats and others. \nWHO works with countries to help them prevent\, detect and manage cases of H5N1 virus infection in humans when they occur. WHO collaborates with global health partners and agencies\, including the World Organization for Animal Health (WOAH)\, and the Food and Agriculture Organization of the United Nations (FAO)\, to monitor the risk\, and control and prevent the spread of animal diseases. \nWHO’s global laboratory system\, the Global Influenza Surveillance and Response System (GISRS)\, identifies and monitors strains of circulating influenza viruses\, and provides advice to countries on their risk to human health and available treatment or control measures. WHO works with partners around the world on pandemic preparedness for H5N1 and other animal influenzas. \nInfluenza H5 pathogens have been included in the list of priority pathogens by the WHO R&D Blueprint for Epidemics. To coordinate efforts for research preparedness of H5N1 outbreaks\, this global consultation will review current and novel vaccines and preventive pharmaceuticals. \nPlease visit the World Health Organization’s website for more information and to register.
URL:https://globalbiodefense.com/event/what-research-is-important-to-prepare-for-h5n1-outbreaks/
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250325T120000
DTEND;TZID=America/New_York:20250325T130000
DTSTAMP:20250322T191531Z
CREATED:20250322T191453Z
LAST-MODIFIED:20250322T191531Z
UID:62284-1742904000-1742907600@globalbiodefense.com
SUMMARY:Unique Capabilities of Cryo-EM in Structure Determination and its Potential in Drug Discovery
DESCRIPTION:As part of Advancing Drug Discovery: A Webinar Series of the National Academies of Sciences\, Engineering and Medicine\, a session on Unique Capabilities of Cryo-EM in Structure Determination and its Potential in Drug Discovery will be held on March 25th\, 2025. \nCryo-EM has emerged as a powerful structural technique that is generally applicable to samples spanning from single proteins to large viruses\, including integral membrane proteins and large macromolecular assemblies\, even when they are flexible or involve transient\, regulatory interactions. The minimal requirement concerning sample amount and the capacity to describe conformational ensembles make cryo-EM the technique of choice when characterizing samples that challenge methods like NMR or crystallography. \nThe resolution of the structures obtained by cryo-EM has been increasing with improvement in hardware and software\, making it relevant in the drug discovery arena. \nDr. Eva Nogales\, Distinguished Professor in Molecular and Cell Biology at the University of California\, Berkeley\, will introduce the technique and demonstrate its capability in studies of the microtubule cytoskeleton\, molecular machinery involved in gene expression regulation\, and other biological systems that had defied structural characterization by more traditional methods. \nPlease visit the National Academies’ Unique Capabilities of Cryo-EM in Structure Determination and its Potential in Drug Discovery event page for more information and to register.
URL:https://globalbiodefense.com/event/unique-capabilities-of-cryo-em-in-structure-determination-and-its-potential-in-drug-discovery/
LOCATION:
END:VEVENT
END:VCALENDAR